Systemic infections and inflammation affect chronic neurodegeneration
The DOI matches its Crossref record; 91 of the 93 references it cites were found in a registry or an index.
Abstract
It is well known that systemic infections cause flare-ups of disease in individuals with asthma and rheumatoid arthritis, and that relapses in multiple sclerosis can often be associated with upper respiratory-tract infections. Here we review evidence to support our hypothesis that in chronic neurodegenerative diseases such as Alzheimer's disease, with an ongoing innate immune response in the brain, systemic infections and inflammation can cause acute exacerbations of symptoms and drive the progression of neurodegeneration.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“chronic systemic inflammation, mostly in the form of infections, has long been associated with behavioral alterations and cognitive dysfunction (50, 51).”
From The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication (2020) · cites this paper as [51]
In the citing paper
“gene expression by morphologically identical microglia can differ drastically contingent on context (Perry et al., 2007).”
From Differential roles of microglia and monocytes in the inflamed central nervous system (2014) · cites this paper as Perry et al., 2007
In the citing paper
“Both of these phenomena can be explained by the concept of phenotypic heterogeneity of microglial cell populations100.”
From From inflammation to sickness and depression: when the immune system subjugates the brain (2008) · cites this paper as [100]
In the citing paper
“For example, chronic neurodegenerative diseases are associated with increasing numbers of microglia100.”
From From inflammation to sickness and depression: when the immune system subjugates the brain (2008) · cites this paper as [100]
In the citing paper
“Furthermore, with the deposition of Aβ, the phenotype of microglial cells becomes more neurotoxic118,146–148: they express several inflammatory cytokines, including IL-1β, IL-6, tumour necrosis factor (TNF) and CCL3 (also known as MIP1α)146.”
From Microglial signatures and their role in health and disease (2018) · cites this paper as [147]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)
Hu, R. J. (2003) · Encyclopedia of the Neurological Sciences · doi:10.1016/b0-12-226870-9/01070-4 · Cited by 9,117
Alternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189 · cited 1×
“It is widely recognized that cells of the macrophage lineage exist in many states of activation, including pro-inflammatory, alternatively activated or even anti-inflammatory, following the ingestion of apoptotic cell”
BackgroundResting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
Nimmerjahn, A., Kirchhoff, F., & Helmchen, F. (2005) · Science · doi:10.1126/science.1110647 · Cited by 5,827 · cited 1×
“Although the microglia are phenotypically downregulated, recent imaging studies in vivo show that these cells, even in their so-called resting state, are highly active, with their fine processes continually surveying their local microenvironmen”
BackgroundInflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Microglia: a sensor for pathological events in the CNS
Kreutzberg, G. W. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10049-7 · Cited by 4,396 · cited 1×
“Microglia are exquisitely sensitive to almost any disturbance of brain homeostasi”
BackgroundTracey, K. J. (2002) · Nature · doi:10.1038/nature01321 · Cited by 3,728 · cited 1×
“First, inflammatory events in the thoracic abdominal cavity are signalled to the brain through vagal-nerve sensory afferents, and in turn the vagal efferent outflow might modify these inflammatory events through acetylcholine secretio”
BackgroundImmunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Biological basis of the behavior of sick animals
Hart, B. L. (1988) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(88)80004-6 · Cited by 2,223
Diabetes mellitus and the risk of dementia: The Rotterdam Study
Ott, A., Stolk, R. P., van Harskamp, F., Pols, H. A. P., Hofman, A., & Breteler, M. M. B. (1999) · Neurology · doi:10.1212/wnl.53.9.1937 · Cited by 2,175
Bard, F., Cannon, C., Barbour, R., Burke, R.-L., Games, D., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., et al. (2000) · Nature Medicine · doi:10.1038/78682 · Cited by 2,012
Cited by
Items 501–600 of 1,000
Uncoupling of neurodegeneration and gliosis in a murine model of juvenile cortical lesion
Sargin, D., Hassouna, I., Sperling, S., Sirén, A., & Ehrenreich, H. (2009) · Glia · doi:10.1002/glia.20797 · Cited by 35
“…inflammation has been implicated for different degenerative diseases (Block and Hong, 2005; Hanisch and Kettenmann, 2007; Miller and Streit, 2007; Perry et al., 2007), even though there is increasing evidence of even protective roles of microglia under certain circumstances (Schwartz et al.,…”
BackgroundSulfhydryl-mediated redox signaling in inflammation: role in neurodegenerative diseases
Miller, O. G., & Mieyal, J. J. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1496-7 · Cited by 40
Peng, M., Wang, Y., Wang, F., Chen, C., & Wang, C.-Y. (2012) · Journal of Surgical Research · doi:10.1016/j.jss.2012.08.030 · Cited by 40
“Other studieshave indicated that elevated expression of proinflammatory cytokines results in impairments in long-termpotentiation [32,33] andperformance deficits in hippocampal-mediated cognitive tests [34,35].”
BackgroundNeuroimmune mechanisms in fetal alcohol spectrum disorder
Kane, C. J. M., Phelan, K. D., & Drew, P. D. (2012) · Developmental Neurobiology · doi:10.1002/dneu.22035 · Cited by 40
“Instead, microglial activation can occur along a continuum which may be associated with distinct functional states (Streit et al., 1999; Schwartz et al., 2006; Carson et al., 2007; Hanisch and Kettenmann, 2007; Perry et al., 2007; Colton, 2009).”
BackgroundWhen the infectious environment meets the AD brain
Ganz, T., Fainstein, N., & Ben-Hur, T. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00559-3 · Cited by 39
Ohm, M., Hosseini, S., Lonnemann, N., He, W., More, T. H., Goldmann, O., Medina, E., Hiller, K., & Körte, M. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03188-3 · Cited by 39
“…inflammatory processes triggered by lipopolysaccharide (LPS), the most common antigen on the cell surface of most Gram-negative bacteria, lead to neuronal death and neurodegeneration, particularly in the hippocampus, a brain area of high importance for processes of learning and memory [2–7].”
BackgroundAlzheimer’s Disease and Porphyromonas gingivalis: Exploring the Links
Shawkatová, I., Ďurmanová, V., & Javor, J. (2025) · Life · doi:10.3390/life15010096 · Cited by 39
Tyrphostin AG126 exerts neuroprotection in CNS inflammation by a dual mechanism
Menzfeld, C., John, M., van Rossum, D., Regen, T., Scheffel, J., Jáňová, H., Götz, A. A., Ribes, S., Nau, R., Borisch, A., et al. (2015) · Glia · doi:10.1002/glia.22803 · Cited by 39
“The CNS is especially vulnerable to dysregulated inflammatory processes often associating with infection, trauma, stroke, neurodegenerative or autoimmune diseases, such as multiple sclerosis (MS), the most common CNS autoimmune disease (Murray and Smale, 2012; Perry et al., 2007).”
BackgroundKermanshahi, S., Ghanavati, G., Mesrabadi, M. A., Gholami, M., Ulloa, L., Motaghinejad, M., & Safari, S. (2020) · Neurochemical Research · doi:10.1007/s11064-020-03134-8 · Cited by 39
Relationships of inflammation trajectories with white matter volume and integrity in midlife
O’Donovan, A., Bahorik, A. L., Sidney, S., Launer, L. J., & Yaffe, K. S. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.09.006 · Cited by 40
Hedayat, M., Ahmadi, M., Shoaran, M., & Rezaie, J. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121566 · Cited by 39
Prebiotics for depression: how does the gut microbiota play a role?
Yang, Y., Bi, Z., Zhang, S., Si, L., Liu, X., & Li, F. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1206468 · Cited by 39
“Nevertheless, sustained systemic inflammation, frequently precipitated by infectious agents, has been strongly linked with a range of behavioral and cognitive impairments (115, 116).”
BackgroundSystemic and Central Immunity in Alzheimer's Disease: Therapeutic Implications
Butchart, J., & Holmes, C. (2012) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2011.00245.x · Cited by 35
“We have hypothesized that the exposure of partially activated or “primed” microglial cells (arising from their chronic exposure to amyloid or degenerating neurones) to recurrent acute and chronic proinflammatory systemic signals, through one of the proposed communicating channels between the systemic and central innat…”
BackgroundSelf-citationReinhart, P. H., Kaltenbach, L. S., Essrich, C., Dunn, D., Eudailey, J., DeMarco, C. T., Turmel, G. J., Whaley, J. C., Wood, A., Cho, S., et al. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.03.017 · Cited by 39
Friend or foe: the dichotomous impact of T cells on neuro-de/re-generation during aging
Coder, B., Wang, W., Wang, L., Wu, Z., Zhuge, Q., & Su, D.-M. (2017) · Oncotarget · doi:10.18632/oncotarget.12572 · Cited by 36
“For example, long-term use of antiinflammatory drugs reduces the risk for AD and PD by roughly half [158-160], whereas alteration of peripheral inflammation during neurodegenerative disease can significantly alter the disease course [161].”
BackgroundSystemic microbial TLR2 agonists induce neurodegeneration in Alzheimer’s disease mice
Lax, N., Fainstein, N., Nishri, Y., Ben‐Zvi, A., & Ben‐Hur, T. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01738-z · Cited by 39
Henry, V., Paillé, V., Lelan, F., Brachet, P., & Damier, P. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181b767b4 · Cited by 38
“Activated microglia are identified by morphological changes and the expression of specific markers, such as major histocompatibility complex class II and ED1 in the rat (3, 4).”
BackgroundRole of FABP3 as Biomarker in Alzheimer's Disease and Synucleinopathies
Sepe, F. N., Chiasserini, D., & Parnetti, L. (2018) · Future Neurology · doi:10.2217/fnl-2018-0003 · Cited by 38
Microglial activation and neuroinflammation in acute and chronic cognitive deficits in sepsis
Denver, P., & Cunningham, C. M. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110285 · Cited by 37
Self-citationAndraka, J. M., Sharma, N., & Marchalant, Y. (2019) · Neuroscience Research · doi:10.1016/j.neures.2019.08.001 · Cited by 37
Changing Functional Signatures of Microglia along the Axis of Brain Aging
Brawek, B., Skok, M., & Garaschuk, O. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031091 · Cited by 37
“Epidemiological data on neurodegenerative diseases suggest that middle age is a critical period for disease onset and progression, as well as for the identification of promising treatment options able to stop or reverse pathology [58,59].”
BackgroundMicrobiota-Gut-Brain Communication in the SARS-CoV-2 Infection
Manosso, L. M., Arent, C. O., Borba, L. A., Ceretta, L. B., Quevedo, J., & Réus, G. Z. (2021) · Cells · doi:10.3390/cells10081993 · Cited by 38
“However, a non-resolving inflammation or a systemic chronic inflammation can be involved in several diseases [34,35], including cardiovascular disease [36], type 2 diabetes mellitus [37], cancer [38], psychiatric disorders [39], and neurodegenerative disorders [40].”
BackgroundPan, K., & Garaschuk, O. (2022) · The Journal of Physiology · doi:10.1113/jp279521 · Cited by 37
“…on the one hand different (pro-and anti-inflammatory) functional phenotypes can be coupled to similar or even identical morphological phenotypes (Perry et al., 2007), and on the other hand, microglia can switch their function without obvious changes in their morphology (Riester et al., 2020;…”
Nafea, M., Elharoun, M., Abd-Alhaseeb, M. M., & Helmy, M. W. (2022) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-022-02322-3 · Cited by 37
“Furthermore, several studies (Holmes et al. 2009; Perry et al. 2007) suggested that chronic inflammation from the periphery can induce pro-inflammatory cytokines in the CNS by crossing the blood–brain barrier (BBB) and contribute to cognitive decline in AD patients.”
BackgroundDrevets, D. A., Dillon, M. J., Schawang, J. E., Stoner, J. A., & Leenen, P. J. M. (2010) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2010.02.011 · Cited by 37
Can Blood-Circulating Factors Unveil and Delay Your Biological Aging?
Rybtsova, N., Berezina, T. N., Kagansky, A., & Александрович, Р. С. (2020) · Biomedicines · doi:10.3390/biomedicines8120615 · Cited by 36
Neutrophil-lymphocyte ratio as a marker for disability and activity in multiple sclerosis
Fahmi, R. M., Ramadan, B. M., Salah, H., Elsaid, A. F., & Shehta, N. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.102921 · Cited by 36
¿ Can COVID-19 exacerbate multiple sclerosis symptoms? A case series analysis
Michelena, G., Casas, M., Eizaguirre, M. B., Pita, M. C., Cohen, L., Alonso, R. N., Garcea, O., & Silva, B. A. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.103368 · Cited by 36
‘Alzheimer-like’ pathology in a murine model of arterial hypertension
Carnevale, D., & Lembo, G. (2011) · Biochemical Society Transactions · doi:10.1042/bst0390939 · Cited by 34
Methamphetamine abuse, HIV infection, and neurotoxicity.
Reiner, B. C., Keblesh, J. P., & Xiong, H. (2009) · PubMed · Cited by 36
Lee, K. H., Kwon, D. E., Do Han, K., La, Y., & Han, S. H. (2020) · BMC Neurology · doi:10.1186/s12883-020-01776-3 · Cited by 35
Wang, Z.-J., Han, W.-N., Chai, S.-F., Li, Y., Fu, C.-J., Wang, C.-F., Cai, H.-Y., Li, X., Wang, X., Hölscher, C., et al. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.11.022 · Cited by 35
Alzheimer’s Disease: Current Status of Etiopathogenesis and Therapeutic Strategies
Kh, M. I., & Kassem, L. A. A. (2011) · Pakistan Journal of Biological Sciences · doi:10.3923/pjbs.2011.257.272 · Cited by 35
Do Centenarians Die Healthier than Younger Elders? A Comparative Epidemiological Study in Spain
Clerencia-Sierra, M., Ioakeim‐Skoufa, I., Poblador‐Plou, B., González‐Rubio, F., Aza‐Pascual‐Salcedo, M., Machón, M., Miguel, A. G., & Prados‐Torres, A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051563 · Cited by 35
Acute inflammatory response in the skin of gilthead seabream (Sparus aurata) caused by carrageenin
Campos‐Sánchez, J. C., Mayor-Lafuente, J., González‐Silvera, D., Guardiola, F. A., & Esteban, M. Á. (2021) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2021.10.009 · Cited by 36
NLRP3 Exacerbate NETosis-Associated Neuroinflammation in an LPS-Induced Inflamed Brain
Byun, D. J., Lee, J., Yu, J., & Hyun, Y. (2023) · Immune Network · doi:10.4110/in.2023.23.e27 · Cited by 35
“However, when inflammation occurs in the brain, the integrity of the BBB is lost, and the tight junction loosens, allowing immune cells to infiltrate the brain and become susceptible to all pathogens (29-31).”
BackgroundHimaya, S. W. A., Ryu, B., Qian, Z., Li, Y., & Kim, S. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.09.013 · Cited by 35
“These neurotoxic factors produced from activated microglia and the molecules releasing from damaged neurons due to microglial toxins lead to further activation of microglia resulting reactive microgliosis which will lead to adverse chronic inflammation in CNS (Block and Hong, 2005; Perry et al., 2007).”
BackgroundInflammatory pathway analytes predicting rapid cognitive decline in MCI stage of Alzheimer’s disease
Pillai, J. A., Bena, J., Bebek, G., Bekris, L. M., Bonner‐Jackson, A., Kou, L., Pai, A., Sørensen, L., Neilsen, M., Rao, S. M., et al. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51109 · Cited by 36
“The ADmark Alzheimer’s evaluation uses sandwich Enzyme Linked Immunosorbant Assay(ELISA) kits [Innotest b-amyloid[1-42], Innotest hTAU-Ag, Innotest Phospho-Tau[181P], Innogenetics, Ghent, Belgium].”
MethodMultiple System Atrophy: Pathology, Pathogenesis, and Path Forward
Ndayisaba, A., Halliday, G. M., & Khurana, V. (2024) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-051122-104528 · Cited by 35
Hoshino, K., Uchinami, Y., Uchida, Y., Saitô, H., & Morimoto, Y. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.637703 · Cited by 34
“It is a well-known fact that systemic immune challenges exacerbate cognitive decline in patients who are already affected by chronic neurodegenerative diseases such as Alzheimer’s disease (Perry et al., 2007).”
BackgroundFu, C., Lin, J., Gong, G., Zhong, W., Chen, H., & Luo, X. (2021) · Aging Clinical and Experimental Research · doi:10.1007/s40520-021-01919-7 · Cited by 34
Vints, W. A. J., Kušleikienė, S., Sheoran, S., Šarkinaitė, M., Valatkevičienė, K., Gleiznienė, R., Kvedaras, M., Pukėnas, K., Himmelreich, U., Česnaitienė, V. J., et al. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.859772 · Cited by 34
“Moreover, studies have shown that microglia change to a more proinflammatory phenotype with age (20, 21).”
BackgroundSong, B., Tang, X., Wang, X., Huang, X., Ye, Y., Lu, X., Wei, X., & Zeng, Y. (2012) · Cellular Immunology · doi:10.1016/j.cellimm.2012.04.006 · Cited by 34
“The altering peripheral inflammation during brain-related injury can significantly alter diseases course [13].”
BackgroundGlimepiride reduces CD14 expression and cytokine secretion from macrophages
Ingham, V. A., Williams, A., & Bate, C. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-115 · Cited by 34
“Numerous studies suggest that cytokine-induced neuroinflammation contributes to the clinical progression of AD, PD and prion diseases [7-9].”
BackgroundGökçe, Ş. F., Bolayır, A., Çiğdem, B., & Yildiz, B. (2023) · BMC Neurology · doi:10.1186/s12883-023-03101-0 · Cited by 33
“These changes result in several changes, such as demyelinating lesions consistent with myelin damage in the white and gray matter and atrophy, indicating axonal loss in the brain and spinal cord [7].”
BackgroundBharani, K., Derex, R., Granholm, A., & Ledreux, A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0189821 · Cited by 33
Moderate running exercise prevents excessive immune system activation
Scheffer, D. D. L., Ghisoni, K., Aguiar, A. S., & Latini, A. (2019) · Physiology & Behavior · doi:10.1016/j.physbeh.2019.02.023 · Cited by 33
Shim, J.-I., Byun, G., & Lee, J.-T. T. (2023) · Environmental Health · doi:10.1186/s12940-023-00986-9 · Cited by 33
Immune System Contributions to the Pathophysiology of Depression
Miller, A. H., & Raison, C. L. (2008) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.6.1.foc36 · Cited by 33
Repeated systemic inflammation was associated with cognitive deficits in older Britons
Tampubolon, G. (2015) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2015.11.009 · Cited by 33
“Systemic inflammatory markers have been investigated for this purpose in middle aged and older people and have been found to be associated with many cognitive abilities including episodic memory, executive function, and global cognition [3–12].”
BackgroundKulczyńska‐Przybik, A., Słowik, A., Mroczko, P., Borawski, B., Groblewska, M., Borawska, R., & Mroczko, B. (2020) · Current Alzheimer Research · doi:10.2174/1567205017666201109095657 · Cited by 32
Heldmann, U., Mine, Y., Kokaia, Z., Ekdahl, C. T., & Lindvall, O. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.03.005 · Cited by 32
“In fact, microglia can switch to a phenotype contributing to neuronal damage without morphological change (Perry, et al., 2007).”
Dutta, R., & Roy, S. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0341-5 · Cited by 32
“Frequent and repeated systemic infection in various neurodegenerative diseases, such as Alzheimer’s and Parkinson’s disease, results in unregulated activation of proinflammatory cytokines in the central nervous system (CNS) leading to progressive decline in cognitive function [5, 6].”
Inflammatory Mediators in the Frontal Lobe of Patients with Mixed and Vascular Dementia
Mulugeta, E., Molina-Holgado, F., Elliott, M. S., Hortobagyi, T., Perry, R., Kalaria, R. N., Ballard, C. G., & Francis, P. T. (2008) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000118633 · Cited by 29
How Predictive of Dementia are Peripheral Inflammatory Markers in the elderly?
Metti, A. L., & Cauley, J. A. (2012) · Neurodegenerative Disease Management · doi:10.2217/nmt.12.68 · Cited by 32
Chamera, K., Szuster-Głuszczak, M., Trojan, E., & Basta-Kaim, A. (2020) · Cells · doi:10.3390/cells9071676 · Cited by 31
“Upon exposure to a pro-inflammatory stimulus, primed microglia exhibit an excessive inflammatory response [23], suggesting that inhibitory control over microglia has been attenuated.”
BackgroundThinking outside the brain for cognitive improvement: Is peripheral immunomodulation on the way?
Zheng, X., Zhang, X., An, K., Ran, C., Wang, G., & Hao, H. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.06.020 · Cited by 32
“…to only restricted in the brain, it is now apparent that the sensors andmodulators of cerebral microenvironment also reside in the periphery (Perry et al., 2007; van Gool et al., 2010), which prompts us to re-evaluate the current dogma about CNS disease pathology and explore how this trait…”
Ganz, T., Fainstein, N., Elad, A., Lachish, M., Goldfarb, S., Einstein, O., & Ben‐Hur, T. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02369-8 · Cited by 31
Yang, Y., García-Cruzado, M., Zeng, H., Camprubí-Ferrer, L., Bahatyrevich-Kharitonik, B., Bachiller, S., & Deierborg, T. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.07.006 · Cited by 33
Persistent low-grade inflammation and regular exercise
Pedersen, B. K. (2010) · Frontiers in Bioscience-Scholar · doi:10.2741/s48 · Cited by 31
“In addition, it appears that systemic inflammation may further stimulate the progression of these neurological disorders (14).”
BackgroundRAGE signaling contributes to neuroinflammation in infantile neuronal ceroid lipofuscinosis
Saha, A., Kim, S., Zhang, Z., Lee, Y., Sarkar, C., Tsai, P., & Mukherjee, A. B. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.10.015 · Cited by 31
“reported that neuroinflammation resulting from systemic infection may also hasten the progression of chronic neurodegeneration reviewed in [2].”
BackgroundSurgery and Anesthesia: Healing the Body but Harming the Brain?
Crosby, G. J., & Culley, D. J. (2011) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3182160431 · Cited by 31
Exposure to general anesthesia and the risk of dementia
Fuh, J., & Yang, C.-W. (2015) · Journal of Pain Research · doi:10.2147/jpr.s55579 · Cited by 31
“oligomers, or senile plaques activate astrocytes and microglia, the immune cells in the brain.(50) Peripheral inflammatory”
Role of TLR4 Polymorphisms in Inflammatory Responses: Implications for Unsuccessful Aging
Balistreri, C. R., Candore, G., Listì, F., Fazio, T., GANGI, S., Incalcaterra, E., Caruso, M., Vecchi, M. L., Lio, D., & Caruso, C. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1404.003 · Cited by 31
Hölscher, C. (2025) · CNS Drugs · doi:10.1007/s40263-025-01226-z · Cited by 30
“These kinases block insulin signaling and other growth-factor signaling pathways [21, 45–51].”
Wang, W., Nakashima, K., Hirai, T., & Inoue, M. (2019) · Journal of Natural Medicines · doi:10.1007/s11418-018-01277-1 · Cited by 30
Ding, F., Wang, X., Zhang, L., Li, J., Liu, F., & Wang, L. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14266 · Cited by 30
Lind, A., Boraxbekk, C., Petersen, E. T., Paulson, O. B., Andersen, O., Siebner, H. R., & Marsman, A. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15456 · Cited by 31
“Both astrocytes and microglia increase their secretion of pro-inflammatory cytokines, and astrocytes undergo senescence whereas microglia become primed and more responsive to inflammatory stimuli (Cohen and Torres, 2019; Perry et al., 2007).”
BackgroundButterfield, D. A., Favia, M., Spera, I., Campanella, A., Lanza, M., & Castegna, A. (2022) · Molecules · doi:10.3390/molecules27030951 · Cited by 31
Fernández-Montesinos, R., Torres, M., Baglietto‐Vargas, D., Gutiérrez, A., Gozes, I., Vitórica, J., & Pozo, D. (2009) · Journal of Molecular Neuroscience · doi:10.1007/s12031-009-9300-x · Cited by 31
“Therefore, ADNP/NAP could have a dual role as a neuroprotector and an immunomodulator, an interesting feature for therapeutic interventions in diseases with immune-unbalanced components such as AD (Perry et al. 2007; Popescu 2007; Castellani et al. 2008; Jimenez et al. 2008).”
BackgroundT cells and microglia as drivers of multiple sclerosis pathology
Friese, M. A., & Fugger, L. H. (2007) · Brain · doi:10.1093/brain/awm246 · Cited by 29
Deciphering variability in the role of interleukin-1β in Parkinson’s disease
Saghazadeh, A., Ferrari, C. C., & Rezaei, N. (2016) · Reviews in the Neurosciences · doi:10.1515/revneuro-2015-0059 · Cited by 30
Chu, J. M. T., Xiong, W., Linghu, K., Liu, Y., Zhang, Y., Zhao, G. D., Irwin, M. G., Wong, G. T. C., & Yu, H. (2018) · Experimental Neurobiology · doi:10.5607/en.2018.27.6.564 · Cited by 30
“It is well established that peripheral inflammation could trigger a neuroinflammatory response in the brain [15].”
BackgroundNew Insights into Immune-Mediated Mechanisms in Parkinson’s Disease
Tan, J. S. Y., Chao, Y., Rötzschke, O., & Tan, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239302 · Cited by 30
“This arises from the activated phenotype of microglia that may be primed by ongoing systemic inflammation in PD patients [24].”
BackgroundLongitudinal Associations Between Serum Cytokine Levels and Dementia
Kim, J.-W., Stewart, R., Kang, H.-J., Bae, K.-Y., Kim, S.-W., Shin, I.-S., Yoon, J.-S., & Kim, J.-M. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00606 · Cited by 29
“Therefore, when conditions other than aging occur that can accelerate inflammation, such as amyloid plaques and neurofibrillary tangles (9), depression (9), genetic conditions (41), infections (42), trauma, and vascular events (8), immune sensitization can occur, which can accelerate cognitive impairment.”
BackgroundRecent Advances in ROS-Scavenging Metallic Nanozymes for Anti-Inflammatory Diseases: A Review
Mohapatra, A., & Park, I. (2023) · Chonnam Medical Journal · doi:10.4068/cmj.2023.59.1.13 · Cited by 29
“When acute inflammation is not resolved effectively, it leads to chronic inflammation, which further morphs into autoimmune or inflammatory disorders such as inflammatory bowel disease, rheumatoid arthritis, Alzheimer’s disease, and atherosclerosis.(16-20) Therefore, it is important to develop therapeutically effectiv…”
BackgroundLai, P.-H., Wang, T.-H., Zhang, N.-Y., Wu, K.-C., Yao, C. J., & Lin, C. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02086-2 · Cited by 29
“In addition to synovial inflammation and cartilage damage, systemic inflammation is a hallmark of RA that can lead to altered gene expression in many tissues [21, 49] and contribute to neurodegeneration [30].”
BackgroundA TLR/CD44 axis regulates T cell trafficking in experimental and human multiple sclerosis
Tredicine, M., Camponeschi, C., Pirolli, D., Lucchini, M., Valentini, M., Geloso, M. C., Mirabella, M., Fidaleo, M., Righino, B., Moliterni, C., et al. (2022) · iScience · doi:10.1016/j.isci.2022.103763 · Cited by 29
“It is known that infectious episodes often drive flares of MS (Perry et al., 2007).”
BackgroundImpact of asthma on the brain: evidence from diffusion MRI, CSF biomarkers and cognitive decline
Nair, A., Hulle, C. V., Bendlin, B., Zetterberg, H., Blennow, K., Wild, N., Kollmorgen, G., Suridjan, I., Busse, W., Dean, D., et al. (2023) · Brain Communications · doi:10.1093/braincomms/fcad180 · Cited by 24
“mation are associated with increased neuroinflammation and accelerated cognitive decline, and the impact is higher in those with chronic inflammation.(3,4) At the same time, it is well-recognized that neuropathological changes appear decades before clinical manifestations of dementia, with multiple pathways determinin…”
Guerrero‐Carrasco, M., Targett, I. L., Olmos‐Alonso, A., Vargas‐Caballero, M., & Gómez‐Nicola, D. (2024) · Glia · doi:10.1002/glia.24532 · Cited by 29
Edgar, J. M., & Griffiths, I. R. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-374709-9.00005-5 · Cited by 29
More, S. V., Park, J., Kim, B.-W., Kumar, H., Lim, H.-W., Kang, S.-M., Koppula, S., Yoon, S., & Choi, D. (2013) · Journal of Pharmacological Sciences · doi:10.1254/jphs.12170fp · Cited by 29
sPhospholipase A2 is inhibited by anthocyanidins
Dreiseitel, A., Korte, G., Schreier, P. H., Oehme, A., Locher, S., Hajak, G., & Sand, P. G. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0268-z · Cited by 29
“Although oxidative stress (Cantuti-Castelvetri et al. 2003) and inflammatory reactions ( Perry et al. 2007 ) both contribute to age-related pathologies, antioxidant activity alone does not explain the potency of berry constituents in protecting against neurodegeneration (Shukitt-Hale et al. 2008).”
BackgroundThe role of neutrophil granulocytes in immune-to-brain communication
Pflieger, F. J., Hernandez, J., Schweighöfer, H., Herden, C., Rosengarten, B., & Rummel, C. D. (2018) · Temperature · doi:10.1080/23328940.2018.1538598 · Cited by 29
“Thus, systemic inflammation can affect chronic neurodegeneration [70] partially related to immunecell trafficking to the brain.”
BackgroundNeuroimmune nexus of depression and dementia: Shared mechanisms and therapeutic targets
Herman, F. J., Simkovic, S. J., & Pasinetti, G. M. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14569 · Cited by 29
Kan, M., Yang, T., Fu, H. Q., Fan, L., Wu, Y., Terrando, N., & Wang, T. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00175 · Cited by 29
“These events may predispose to significant complications, non-resolved inflammation, and persistent cognitive impairments especially to frail and elderly subjects (Perry et al., 2007; Cunningham et al., 2009).”
BackgroundInfluence of Adolescent Heavy Session Drinking on the Systemic and Brain Innate Immune System
Ward, R. J., Lallemand, F., & Witte, P. D. (2014) · Alcohol and Alcoholism · doi:10.1093/alcalc/agu002 · Cited by 28
Total Sleep Time Interacts With Age to Predict Cognitive Performance Among Adults
Mohlenhoff, B. S., Insel, P. S., Mackin, R. S., Neylan, T. C., Flenniken, D., Nosheny, R. L., Richards, A. L., Maruff, P. T., & Weiner, M. W. (2018) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.7342 · Cited by 28
“40 It is also possible that longer sleep durations associated with poorer cognitive performance do not promote a distinct disease process but instead represent incomplete compensation for impaired sleep quality by increased TST.”
Daμμe, M., Stroobants, S., Walkley, S. U., Lüllmann‐Rauch, R., D’Hooge, R., Fogh, J. M., Säftig, P., Lübke, T., & Blanz, J. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31820428fa · Cited by 28
Schäfer, A., Whitmore, A. C., Konopka, J. L., & Johnston, R. E. (2009) · Journal of Virology · doi:10.1128/jvi.02383-08 · Cited by 24
“IL-6 has been described as an acute-phase protein with a variety of effects on the expression of other cytokines and mediators of inflammation (38).”
BackgroundEtanercept in Alzheimer disease: A randomized, placebo-controlled, double-blind, phase 2 trial
Tufan, A. N., & Tufan, F. (2015) · Neurology · doi:10.1212/01.wnl.0000475736.75775.25 · Cited by 25
Zhu, H., Liang, Y., Hao, W., Ma, Q., Xiao-juan, L., Li, Y.-M., & Chen, J. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/6673538 · Cited by 27
Evans, A. K., Park, H. H., Saw, N. L., Singhal, K., Ogawa, G., Leib, R. D., & Shamloo, M. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.06.012 · Cited by 27
van Ton, A. M. P., Leijsen, E. M. C. M.-V., Bergkamp, M. I., Bronkhorst, E. M., Pickkers, P., de Leeuw, F., Tuladhar, A. M., & Abdo, W. F. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005313 · Cited by 27
“Our results address an important issue within this research field: what is the direction of the interaction between systemic inflammation and the brain (6, 24, 25)? It is commonly accepted that systemic inflammation increases the risk for cognitive decline and dementia (9, 26, 27), but often data on preexisting cerebr…”
BackgroundImmunology primer for neurosurgeons and neurologists part 2: Innate brain immunity
Blaylock, R. L. (2013) · Surgical Neurology International · doi:10.4103/2152-7806.118349 · Cited by 29
“The peripheral immune stimulation by way of the interacting process discussed earlier, fully activate the primed microglia in an exaggerated manner.[119]”
BackgroundBottoms up: the role of gut microbiota in brain health
Radisavljevic, N., Cirstea, M., & Brett Finlay, B. (2019) · Environmental Microbiology · doi:10.1111/1462-2920.14506 · Cited by 22
Impaired Olfaction and Risk of Delirium or Cognitive Decline After Cardiac Surgery
Brown, C. H., Morrissey, C. K., Ono, M., Yenokyan, G., Selnes, O. A., Walston, J. D., Max, L. K., Laflam, A., Neufeld, K. J., Gottesman, R. F., et al. (2015) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13198 · Cited by 27
“Recent evidence has emerged that the microglia in elderly adults with chronic neurodegenerative disease may be “primed” for an inflammatory insult.(35) After exposure of primed microglia to an inflammatory insult, such as surgery and cardiopulmonary bypass, an exaggerated microglial response with high cytokine express…”
BackgroundCerebral emboli in the genesis of dementia
Purandare, N. B., & Burns, A. S. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.02.306 · Cited by 27
“In patients with dementia, SCE may be associated with factors not examined in our study such as the abnormalities of platelet activation [32] or inflammatory markers [33] or the associations with individual risk factors may not be detected if SCE were universal in dementia.”
BackgroundDezfulian, M. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.04.012 · Cited by 27
Selective neuronal vulnerability in Alzheimer’s disease
Wang, Z.-T., Zhang, C. M., Wang, Y., Dong, Q., Tan, L., & Yu, J. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101114 · Cited by 26
Metadata
- Authors
- Perry, V. H., Cunningham, C., & Holmes, C.
- Affiliations
- University of Southampton (GB)
- Corresponding author
- Perry, V. Hugh
- Venue
- Nature Reviews Immunology
- Published
- 2007-01-15
- Volume
- 7
- Issue
- 2
- Pages
- 161-167
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W1970606114
- Cited by
- 1,027
- References
- 93
- Citations by year
- 2026: 30 · 2025: 40 · 2024: 61 · 2023: 34 · 2022: 52 · 2021: 69 · 2020: 73 · 2019: 50 · 2018: 56 · 2017: 44 · 2016: 54 · 2015: 63 · 2014: 66 · 2013: 58 · 2012: 62
- FWCI
- 4.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- Funders
- Wellcome Trust
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- systemic infection, inflammation, chronic neurodegeneration, neuroinflammation, Alzheimer's disease, innate immune response, disease exacerbation, multiple sclerosis relapse, upper respiratory tract infection
- MeSH terms
- Aging, Animals, Brain, Communicable Diseases, Humans, Inflammation, Microglia, Neurodegenerative Diseases, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.